Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000728889-03-000095
Filing Date
2003-02-12
Accepted
2003-02-12 17:22:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 BODY myriadgeneticsbody.htm SC 13G 11528
  Complete submission text file 0000728889-03-000095.txt   13609
Mailing Address 498 SEVENTH AVENUE 14TH FLOOR NEW YORK NY 10018
Business Address 498 SEVENTH AVENUE 14TH FLOOR NEW YORK NY 10018 212-323-0200
OPPENHEIMER FUNDS INC (Filed by) CIK: 0000728889 (see all company filings)

State of Incorp.: CO | Fiscal Year End: 1231
SIC: 0000

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-49156 | Film No.: 03555552
SIC: 2835 In Vitro & In Vivo Diagnostic Substances